Value Aligned Research Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.3M Hold
568,316
0.3% 50
2025
Q4
$94.5M Sell
568,316
-810,035
-59% -$136M 0.95% 34
2025
Q3
$270M Buy
1,378,351
+197,320
+17% +$32.4M 3.3% 14
2025
Q2
$107M Sell
1,181,031
-152,167
-11% -$12M 2.26% 17
2025
Q1
$79.6M Buy
1,333,198
+1,187,450
+815% +$110M 5.8% 6
2024
Q4
$19.3M Buy
+145,748
New +$13.7M 5.28% 8
2024
Q3
Sell
-249,891
Closed -$15.1M 35
2024
Q2
$15.1M Buy
249,891
+224,465
+883% +$15.6M 3.31% 12
2024
Q1
$1.89M Buy
+25,426
New +$1.88M 0.37% 18

Other funds holding ALAB

Value Aligned Research Advisors's ALAB Position: Q1 2026 in Review

Value Aligned Research Advisors held its Astera Labs (ALAB) position steady in Q1 2026 at 568,316 shares worth $62.3M. The position accounts for 0.3% of the portfolio, ranked #50.

Value Aligned Research Advisors first reported a position in ALAB in Q1 2024 and has held it in 8 quarters since. The position peaked at $270M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Value Aligned Research Advisors held 568,316 shares of Astera Labs worth $62.3M as of Q1 2026.
  • Value Aligned Research Advisors left its Astera Labs share count unchanged in Q1 2026.
  • Astera Labs made up 0.3% of Value Aligned Research Advisors's portfolio in Q1 2026, its #50 holding.
  • Value Aligned Research Advisors first reported a position in Astera Labs in Q1 2024 and has held it in 8 quarters since.
  • Value Aligned Research Advisors's Astera Labs position peaked at $270M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Value Aligned Research Advisors's 13F filing for Q1 2026, filed 18 May 2026.